| Title: |
Phase II trial of neoadjuvant osimertinib for surgically resectable EGFR -mutated non-small cell lung cancer. |
| Authors: |
Aredo, Jacqueline V., Urisman, Anatoly, Gubens, Matthew A., Mulvey, Claire, Allen, Greg M., Rotow, Julia K., Kerr, Daniel Lucas, Chakrabarti, Turja, Bacaltos, Bianca, Gee, Megan, Jones, Kirk, Aisner, Dara L., Patil, Tejas, Schenk, Erin Lynn, Bivona, Trever G., Riess, Jonathan W., Coleman, Melissa, Kratz, Johannes Ruediger, Jablons, David, Blakely, Collin M. |
| Source: |
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p8508-8508, 1p |
| Database: |
Supplemental Index |
